Clostridium Difficile Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Initial Vancomycin Taper for the Prevention of Recurrent Clostridium Difficile Infection
Condition: Clostridium Difficile Infection Interventions: Drug: Vancomycin; Drug: Placebos Sponsors: Todd Lee; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2019 Category: Research Source Type: clinical trials
